Biotech News
GH Research Announces Appointment of Vanina Popova, MD, as Chief Development Officer
Dr. Popova will lead the clinical development of GH001 as the company advances toward pivotal programs in TRD and PPD Brings more than 20 years of global pharmaceutical R&D experience at Johnson & Johnson across clinical operations, clinical development, regulatory strategy, and neuroscience
